[ad_1]
The General Directorate of Health and Infarctions should be about to announce the suspension of the administration of the AstraZeneca vaccine in Portugal.
The news is advanced by SIC Notícias, at a time when a press conference was announced, which must begin at any time, and which will be attended by Graça Freitas, from the DGS, the president of Infarmed and the task force coordinator for the vaccination against COVID-19.
SIC also adds that the indication has already been transmitted to health centers, which should immediately stop using the Oxford University vaccine.
The decision must be made at a time when several countries have also announced the suspension of the administration of this vaccine, and after the European Medicines Agency (EMA) itself defended today that “the benefits” of the AstraZeneca vaccine against covid-19 “outweigh the risks of side effects”, still guaranteeing a “rigorous analysis” of the situations of blood clot formation in those vaccinated.
“While the investigation is ongoing, EMA continues to consider the benefits of the AstraZeneca vaccine to prevent covid-19, with the associated risk of hospitalization and death [devido à pandemia], outweigh the risks of side effects, “says the European regulator in a press release.
At a time when “several authorities responsible for national vaccination campaigns in EU countries have decided to make a temporary pause” in the use of the AstraZeneca vaccine, the EMA clarifies that this decision translates into a “precaution taken to the light of their national situation. “
